Antibodies from patients with rheumatoid arthritis and systemic lupus erythematosus recognize different epitopes of a single heterogeneous nuclear rnp core protein

Antibodies to recombinant heterogeneous nuclear RNP core protein A1 were detected in sera from 27 of 58 patients with rheumatoid arthritis (RA) and from 7 of 31 patients with systemic lupus erythematosus, by immunoblotting and enzyme‐linked immunosorbent assay. Protein A1 consists of 2 distinct doma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis and rheumatism 1990-02, Vol.33 (2), p.180-186
Hauptverfasser: Montecucco, Carlomaurizico, Caporali, Roberto, Negri, Claudia, Gennaro, Fabio De, Cerino, Antonella, Bestagno, Marco, Cobianchi, Fabio, Astaldi‐Ricotti, Giulia C. B.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antibodies to recombinant heterogeneous nuclear RNP core protein A1 were detected in sera from 27 of 58 patients with rheumatoid arthritis (RA) and from 7 of 31 patients with systemic lupus erythematosus, by immunoblotting and enzyme‐linked immunosorbent assay. Protein A1 consists of 2 distinct domains: The N‐terminal sequence is identical to a single‐stranded DNA binding protein termed UP1, and the Ckerminal domain shows a partial homology with keratin. All 7 Al‐positive systemic lupus erythematosus sera reacted with UP1, whereas 9 of the 27 Al‐positive RA sera did not. In RA, anti‐A1 activity was significantly associated with antikeratin antibodies (AKA); these antibodies were present in 23 of 27 Al‐positive sera and 10 of 31 Al‐negative sera (P > 0.01). Immunoabsorption with recombinant protein A1 resulted in a significant reduction of AKA titers in 6 of 10 RA sera tested, suggesting that AKA from RA patients may cross‐react with the C‐terminal portion of the heterogeneous nuclear RNP protein Al.
ISSN:0004-3591
1529-0131
DOI:10.1002/art.1780330205